Frontage Holdings Corp. (HK:1521) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Frontage Holdings Corporation has announced the renewal of its Services Framework Agreement set to expire on 31 December 2024, extending it for three years until 31 December 2027. The agreement, which involves providing laboratory and bioequivalence studies services, will be subject to reporting, announcement, and annual review requirements, but is exempt from shareholder approval. This renewal signifies a continuing partnership between Frontage Holdings Corp. and Hangzhou Tigermed, a controlling shareholder and connected person.
For further insights into HK:1521 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue